In a placebo-controlled , double-blind , parallel-group trial , we investigated @ postmenopausal women ( @ in the placebo group and @ in the medroxyprogesterone acetate -LSB- MPA -RSB- group ) whose SDB had been treated with nasal CPAP for @ months to @ years prior to study entry .